A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris

Status:
Completed

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

This study will identify how much (if any) drug is absorbed from the skin of subjects with acne vulgaris after topical application of SB204.

Phase 1

Novan, Inc.